Income Tax Expense (Benefit) of Core Laboratories Inc. /DE/ from 31 Dec 2021 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Core Laboratories Inc. /DE/ quarterly and annual Income Tax Expense (Benefit) in USD history and change rate from 31 Dec 2021 to 30 Sep 2025.
  • Core Laboratories Inc. /DE/ Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was $3,754,000, a 20% decline year-over-year.
  • Core Laboratories Inc. /DE/ Income Tax Expense (Benefit) for the twelve months ending 30 Sep 2025 was $11,487,000, a 38% decline year-over-year.
  • Core Laboratories Inc. /DE/ annual Income Tax Expense (Benefit) for 2024 was $14,034,000, a 235% increase from 2023.
  • Core Laboratories Inc. /DE/ annual Income Tax Expense (Benefit) for 2023 was $4,185,000, a 59% decline from 2022.
  • Core Laboratories Inc. /DE/ annual Income Tax Expense (Benefit) for 2022 was $10,296,000, a 35% decline from 2021.
Source SEC data
View on sec.gov
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

Core Laboratories Inc. /DE/ Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $11,487,000 $3,754,000 -$937,000 -20% 01 Jul 2025 30 Sep 2025 10-Q 23 Oct 2025 2025 Q3
Q2 2025 $12,424,000 $1,911,000 -$1,698,000 -47% 01 Apr 2025 30 Jun 2025 10-Q 25 Jul 2025 2025 Q2
Q1 2025 $14,122,000 $1,746,000 +$88,000 +5.3% 01 Jan 2025 31 Mar 2025 10-Q 28 Apr 2025 2025 Q1
Q4 2024 $14,034,000 $4,076,000 -$4,453,000 -52% 01 Oct 2024 31 Dec 2024 10-K 13 Feb 2025 2024 FY
Q3 2024 $18,487,000 $4,691,000 +$2,386,000 +104% 01 Jul 2024 30 Sep 2024 10-Q 23 Oct 2025 2025 Q3
Q2 2024 $16,101,000 $3,609,000 +$10,868,000 01 Apr 2024 30 Jun 2024 10-Q 25 Jul 2025 2025 Q2
Q1 2024 $5,233,000 $1,658,000 +$1,048,000 +172% 01 Jan 2024 31 Mar 2024 10-Q 28 Apr 2025 2025 Q1
Q4 2023 $4,185,000 $8,529,000 01 Oct 2023 31 Dec 2023 10-K 13 Feb 2025 2024 FY
Q3 2023 $2,305,000 -$1,551,000 -40% 01 Jul 2023 30 Sep 2023 10-Q 24 Oct 2024 2024 Q3
Q2 2023 $7,259,000 -$9,048,000 -506% 01 Apr 2023 30 Jun 2023 10-Q 25 Jul 2024 2024 Q2
Q1 2023 $610,000 01 Jan 2023 31 Mar 2023 10-Q 25 Apr 2024 2024 Q1
Q3 2022 $3,856,000 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023 2023 Q3
Q2 2022 $1,789,000 01 Apr 2022 30 Jun 2022 10-Q 27 Jul 2023 2023 Q2

Core Laboratories Inc. /DE/ Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $14,034,000 +$9,849,000 +235% 01 Jan 2024 31 Dec 2024 10-K 13 Feb 2025 2024 FY
2023 $4,185,000 -$6,111,000 -59% 01 Jan 2023 31 Dec 2023 10-K 13 Feb 2025 2024 FY
2022 $10,296,000 -$5,595,000 -35% 01 Jan 2022 31 Dec 2022 10-K 13 Feb 2025 2024 FY
2021 $15,891,000 01 Jan 2021 31 Dec 2021 10-K 15 Feb 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.